Dementia Day 2025 References
Jeremy Koppel, MD – AD Pychois
Nha Nguyen, Jesus Gomar, Jack N. Truong, Janos Barbero, Patrick P. Do, Andrea Rommal, Alice Oh, David Eidelberg, Jeremy Koppel†, An Vo†, for the Alzheimer’s Disease Neuroimaging Initiative* “An artificial intelligence-derived metabolic network predicts psychosis in Alzheimer’s disease” Brain Communications. In Press.
†These authors contributed equally to this work.
Elizabeth Allison, MD – The Realities of a New and Unexpected Diagnosis:
A Perspective
Lewy Body Dementia Information for Patients, Families, and Professionals
Liron Sinvani, MD – Hospital Management of Delirium Behavioral and Psychological Symptoms of Dementia
Arindam Nandi, PhD, MS – The Economic Burden of Dementia in the US and Around the World
Cost of care for Alzheimer’s disease and related dementias in the United States: 2016 to 2060
Marzena Gieniusz, MD – GUIDE Model – A Medicare Benefit to Support Patients Living with Dementia and Their Caregivers.
The Effects of Dementia Care Co-Management on Acute Care, Hospice, and Long-Term Care Utilization
Dementia care navigation: Building toward a common definition, key principles, and outcomes
Crystal Quinn, PhD – Neuropsychology of Dementia
What is a Neuropsychological Evaluation?
Rosemary Gallagher, PT, DPT, PhD – The Role of Community Exercise Programs
Taraldsen, K., Boulton, E., Helbostad, J. L., Saltvedt, I., & Granbo, R. (2020). Client, caregiver, volunteer, and therapist views on a voluntary supported group exercise programme for older adults with dementia. BMC geriatrics, 20, 1-9.
Vseteckova, J., Dadova, K., Gracia, R., Ryan, G., Borgstrom, E., Abington, J., … & Pappas, Y. (2020). Barriers and facilitators to adherence to walking group exercise in older people living with dementia in the community: A systematic review. European review of aging and physical activity, 17, 1-16.
Steichele, K., Keefer, A., Dietzel, N., Graessel, E., Prokosch, H. U., & Kolominsky-Rabas, P. L. (2022). The effects of exercise programs on cognition, activities of daily living, and neuropsychiatric symptoms in community-dwelling people with dementia—a systematic review. Alzheimer’s Research & Therapy, 14(1), 97.
Marc Gordon, MD – Anti-amyloid Treatment and Beyond
Luca Giliberto, MD, PhD – Anti-amyloid Treatment and Beyond
Lecanemab: Appropriate Use Recommendations
Lecanemab in Early Alzheimer’s Disease
Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology
Kaitlin Tangredi, LMSW, CMC
Lewy Body Dementia Association. (2025). Lewy Body Dementia Association. Retrieved February 25, 2025, from https://www.lbda.org/
Jessica Mongelli, NP
